Disclosure notice

As a result of the preferential rights issue in Follicum AB ("Follicum") in October 2017, the holding of the shareholder, Lund University Bioscience AB's has decreased to less than ten percent of votes and equity.Lund University Bioscience AB is one of the main shareholders in Follicum. As a result of the recently completed preferential share issue, in which 10,670,114 new shares were issued, Lund University Bioscience AB's ownership has decreased from 14.5 percent of votes and equity to 8.7 percent of votes and equity. Following the completion of the share issue, Lund University Bioscience